The Christie charity
The table below shows a list of The Lymphoma Group's current clinical trials open for recruitment for rare lymphomas such as:
- Mantle cell lymphoma
- Burkitt's lymphoma
- MALToma (Marginal zone) lymphoma
- CNS (brain) lymphoma
- Waldenström macroglobulinemia
If you would like to know how to access our trials please click here
|
Trial name |
Description |
Click for more information (external page) |
|
GEN3013 |
Phase 1/2 study using antibody GEN3013 to target CD20- expressing cells in patients with B cell non Hodgkin lymphoma
|
|
|
JCAR017 |
Phase 2 study determining efficacy and safety of JCAR017.
|
|
|
GO29781 |
A phase 1/1b trial testing mosunetuzumab, on its own or with atezolizumab. Suitable for patients with lymphoma which has come back after previous treatment
|
|
|
RAINBOW |
A randomised, phase 2/3 trial comparing ibrutinib plus rituximab with standard treatment in people with Waldenström’s macroglobulinaemia.
|
|
|
PembroWM |
A phase 2 trial of rituximab and pembrolizumab in people with relapsed or refractory Waldenström’s macroglobulinaemia.
|
|
|
Mangrove |
A phase 3 trial of zanubrutinib plus rituximab in older people with untreated mantle cell lymphoma.
|
|
With special thanks to the following:
